Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts.

Richard BodyEdward Watts CarltonMatthew SperrinPhilip S LewisGillian BurrowsSimon CarleyGarry McDowellIain BuchanKim GreavesKevin Mackway-Jones

Published in: Emergency medicine journal : EMJ (2016)

T-MACS could 'rule out' ACS in 40% of patients, while 'ruling in' 5% at highest risk using a single hs-cTnT measurement on arrival. As a clinical decision aid, T-MACS could therefore help to conserve healthcare resources.

Keyphrases

acute coronary syndrome
healthcare
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
patient reported outcomes
atrial fibrillation
health insurance